SEC Form 4 · accession 0001209191-18-028735
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth D Krell
Director
Period of report
May 7, 2018
Accepted (ET)
May 9, 2018 · 9:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 7, 2018 | M | 10,000 | $9.30 | A | 29,967 | D | |
| Common StockF1 | May 8, 2018 | S | 10,000 | $22.82 | D | 19,967 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $9.30 | May 7, 2018 | M | 10,000 | D | May 23, 2014 | May 23, 2023 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $22.63 to $22.97 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2These options were granted on May 23, 2013 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.